Regulating transcription factor RUNX1 using small molecule drugs a promising novel therapy for diseases of the retina, including advanced diabetic eye disease.
Yoshihiro Yonekawa, MD, was included in The Ophthalmologist’s 2017 Power List. This list is created by the magazine’s leadership, who vote for ophthalmology’s top 50 rising stars. Dr. Yonekawa joined...
Boston, Mass. — The brains of those who are born blind make new connections in the absence of visual information, resulting in enhanced, compensatory abilities such as a heightened sense of hearing...
Five Ophthalmology residents have been selected for 2017-2018 Heed fellowships by the Heed Ophthalmic Foundation and the Society of Heed Fellows. This accounts for nearly 25% of of all awarded Heed...
Kip Connor, PhD, Assistant Professor of Ophthalmology at Harvard Medical School (HMS), was selected for a 2017 Young Mentor Award, which recognizes faculty who are in the early stages of their careers...
Teresa Chen, MD, Associate Professor of Ophthalmology at Harvard Medical School (HMS), was selected to receive the prestigious HMS 2017 A. Clifford Barger Excellence in Mentoring Award. This award...
Boston, Mass. — It’s the part of the eye exam everyone hates: the pupil-dilating eye drops. The drops work by opening the pupil and preventing the iris from constricting in response to light...
MillennialEYE named Kathryn M. Hatch, MD, an “Outstanding female leader in ophthalmology” in their January/February 2017, and published a profile about her career and work. MillennialEYE is an all...
